Karriereverlauf von Feng Tian
Ehemalige bekannte Positionen von Feng Tian
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 01.07.2018 | 01.11.2020 |
| Vorstandsvorsitzender | 01.07.2018 | 15.08.2022 | |
| Vorsitzender | 01.11.2020 | 15.08.2022 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.07.2018 | |
| Präsident | 01.07.2018 | 15.08.2022 | |
| LuxVitae Therapeutics, Inc. | Gründer | - | - |
| AMBRX INC | Vorstandsvorsitzender | - | - |
| Vorsitzender | - | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 17.06.2015 | - | |
| Präsident | - | - |
Ausbildung von Feng Tian
| Peking University | Undergraduate Degree |
| University of Florida | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| China | 2 |
Operativ
| Chief Executive Officer | 2 |
| Chairman | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
| LuxVitae Therapeutics, Inc. |